Accession Number: | 0001127602-21-019437 |
Date: | 2021-06-07 |
Issuer: | CVS HEALTH CORP (CVS) |
Original Submission Date: |
FINKE DANIEL P
ONE CVS DRIVE
WOONSOCKET, RI 02895
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2021-06-07 | M | 32,320 | a | $54.19 | 60,904 | direct | ||
COMMON STOCK | 2021-06-07 | S | 37,594 | d | $86.60 | 23,310 | direct | ||
COMMON STOCK (PEP) | 2021-06-07 | 0 | $0.00 | 3,042 | direct | ||||
COMMON STOCK (RESTRICTED) | 2021-06-07 | 0 | $0.00 | 25,701 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION | 54.19 | 2021-06-07 | deemed execution date | M | 32,320 (d) | 2020-04-01 | 2029-04-01 | common stock 32,320 | $54.19 | 32,322 | direct | |
STOCK OPTION | 58.34 | 2021-06-07 | deemed execution date | 0 ( ) | 2021-04-01 | 2030-04-01 | common stock 54,332 | $58.34 | 54,332 | direct | ||
STOCK OPTION | 74.3 | 2021-06-07 | deemed execution date | 0 ( ) | 2022-04-01 | 2031-04-01 | common stock 82,066 | $74.30 | 82,066 | direct | ||
STOCK OPTION | 52.37 | 2021-06-07 | deemed execution date | 0 ( ) | 2022-05-31 | 2029-05-31 | common stock 28,640 | $52.37 | 28,640 | direct |
ID | footnote |
---|---|
f1 | all sales were effected pursuant to a rule 10b5-1 plan. |
f2 | represents weighted average sale price for this group of sales, which occurred on the same trading day. multiple sales were executed, with sales prices ranging from $86.52 and $86.71 per share. |
f3 | option became exercisable in four equal annual installments, beginning on 4/1/2020. |
f4 | option became exercisable in four equal annual installments, commencing 4/1/2021. |
f5 | option becomes exercisable in four equal installments, commencing 4/1/2022. |
f6 | option becomes exercisable in three equal installments, commencing 5/31/2022. |